Invention Grant
- Patent Title: Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
-
Application No.: US13200270Application Date: 2011-09-22
-
Publication No.: US09636355B2Publication Date: 2017-05-02
- Inventor: John M. Szabocsik
- Applicant: John M. Szabocsik
- Applicant Address: US MA Cohasset
- Assignee: Theo Holdings, LLC
- Current Assignee: Theo Holdings, LLC
- Current Assignee Address: US MA Cohasset
- Agency: Hinshaw & Culbertson LLP
- Main IPC: A61K9/08
- IPC: A61K9/08 ; A61K31/721 ; A61K31/728 ; A61K31/715 ; A61K9/00 ; A61J1/06
Abstract:
An ophthalmic solution is provided. The ophthalmic solution is hypertonic. The ophthalmic solution includes a polysaccharide having an average molecular weight of between about 40,000 grams per mole and about 150,000 grams per mole. A packaged ophthalmic solution for preventing the ophthalmic solution from being exposed to CO2 and other contaminants is also provided. The ophthalmic solution can be used to treat recurrent corneal erosion. The ophthalmic solution can also be used as a prophylactic to prevent recurrent corneal erosion.
Public/Granted literature
- US20130079301A1 Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion Public/Granted day:2013-03-28
Information query
